Abstracts tagged "methotrexate (MTX) and risk"

Abstract Number: 235 • ACR/ARHP Annual Meeting 2018
Clinical Predictors and Risk of Methotrexate Induced Liver Fibrosis
Sarah Oberholtzer¹ and Lawrence Worobetz², ¹Department of Internal Medicine, University of Saskatchewan, Saskatoon, SK, Canada, ²Department of Internal Medicine, University of Saskatchewan Division of Gastroenterology, Saskatoon, SK, Canada
Background/Purpose: Methotrexate (MTX) is a highly effective therapy for patients with rheumatologic and dermatologic conditions. Its use infers significant reduction in morbidity and mortality; however,…